Aethlon Medical, Inc.
AEMD
$1.59
$0.042.58%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 31.48% | -157.89% | 49.37% | 7.50% | 21.66% |
Total Depreciation and Amortization | -4.07% | -2.21% | -8.42% | -6.13% | -4.65% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 4.78% | 2,953.15% | -72.09% | -1.59% | -45.07% |
Change in Net Operating Assets | -130.08% | 32.29% | -218.83% | 1,430.53% | 30.91% |
Cash from Operations | 1.87% | 34.80% | 15.43% | 18.10% | 29.60% |
Capital Expenditure | -- | 144.90% | 75.00% | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | 144.90% | 75.00% | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | 4,974.10% | -100.00% | -- | 395.75% |
Repurchase of Common Stock | -5.88% | 59.72% | 24.47% | 61.22% | 39.29% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -100.10% | 5,437.79% | -104.01% | 61.22% | 399.14% |
Foreign Exchange rate Adjustments | -1,092.31% | -4.35% | -342.86% | 563.64% | -550.00% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -147.81% | 127.12% | 7.72% | 18.68% | 322.02% |